Anita Åkesson

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192

Christopher P. Denton, Peter A. Merkel, Daniel E. Furst et al. · Arthritis & Rheumatism · 2006 · 451 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

ORGAN MANIFESTATIONS IN 100 PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS: A COMPARISON BETWEEN THE CREST SYNDROME AND DIFFUSE SCLERODERMA

Anita Åkesson, F A Wollheim · Lara D. Veeken · 1989 · 156 citations

Medicine, Immunology, Internal Medicine +14

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

Anita Åkesson, A Scheja, Anders Lundin et al. · Arthritis & Rheumatism · 1994 · 152 citations

Medicine, Pharmacology, Pharmacotherapy +16

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial

Peter A. Merkel, Nancy Silliman, Christopher P. Denton et al. · Arthritis Care & Research · 2008 · 136 citations

Medicine, Clinical Sciences, Dermatology +15

Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane‐associated tumor necrosis factor α

Carlo Chizzolini, Yann Parel, Carmelina De Luca et al. · Arthritis & Rheumatism · 2003 · 111 citations · Full text

Medicine, Immunology, Pathology +17